Section Arrow
Quote
ACXP.NASDAQ
- Acurx Pharmaceuticals
Quotes are at least 15-min delayed:2026/05/05 03:15 EDT
Regular Hours
Last
 2.13
-0.03 (-1.39%)
Day High 
2.24 
Prev. Close
2.16 
1-M High
3.8 
Volume 
99.49K 
Bid
--
Ask
--
Day Low
2.1 
Open
2.2 
1-M Low
1.94 
Market Cap 
6.17M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.13 
20-SMA 2.49 
50-SMA 2.99 
52-W High 21 
52-W Low 1.3259 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.32/-2.09
Enterprise Value
6.22M
Balance Sheet
Book Value Per Share
1.85
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LNAILunai Bioworks Inc.0.3246+0.0047+1.47%-- 
SGMOSangamo Therapeutics0.1776+0.0426+31.56%-- 
CNSPCNS Pharmaceuticals Inc7.84+5.5289+239.23%0PE
CABACabaletta Bio3.83+0.89+30.27%-- 
IOVAIovance Biotherapeutics3.85+0.45+13.24%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.